ALTIVIA Expands Phosgene Derivatives; Starts Production of Bulk Chloroacetyl Chloride

Jan 20, 2016, 12:08 ET from ALTIVIA

HOUSTON, Jan. 20, 2016 /PRNewswire/ -- ALTIVIA announced the completion of facilities at its La Porte, TX manufacturing site to produce Chloroacetyl Chloride.The investment increases ALTIVIA's capabilities in continuous phosgenation to make chloroformates and acid chlorides. Chloroacetyl Chloride, an important industrial building block in the production of pharmaceuticals and agro chemicals, is now available in bulk from the La Porte facility. 

"Expanding ALTIVIA's synthesis capacities in phosgene derivatives increases our product offerings and strengthens our market position," stated Chuck Kreutzberger, PhD, ALTIVIA's Manager of Commercial Development. 

ALTIVIA's production facility in La Porte is a fully integrated phosgene derivative chemicals production site. 

About ALTIVIA
Headquartered in Houston, Texas, privately held ALTIVIA was founded in 1986 and today is the largest merchant producer of Phosgene derivative intermediates in the Americas, including chloroformates and acid chlorides, serving pharmaceutical, organic peroxide and agricultural markets. In November 2015, ALTIVIA acquired the former Sunoco facilities in Haverhill, Ohio, the third largest merchant production facility of Phenol, Acetone and Alpha Methylstyrene in the Americas. ALTIVIA is also a producer of iron-based salts serving municipal and industrial customers with a broad range of chemical solutions, including products formulated for specific water treatment applications.

 

SOURCE ALTIVIA